ASND vs. AU

Last updated Jun 13, 2026

ASND (Ascendis Pharma A/S) and AU (AngloGold Ashanti Limited) are both stocks. ASND operates in Biotechnology (Healthcare), while AU operates in Gold (Basic Materials). Over the past 10 years, ASND returned 33.14%/yr vs 20.46%/yr for AU. At a 0.04 correlation, their price movements are largely independent.

Performance

ASND vs. AU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ascendis Pharma A/S (ASND) and AngloGold Ashanti Limited (AU). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ASND achieves a 2.26% return, which is significantly lower than AU's 4.15% return. Over the past 10 years, ASND has outperformed AU with an annualized return of 33.14%, while AU has yielded a comparatively lower 20.46% annualized return.

ASND

• 1D: 1.14%
• 1M: -10.48%
• YTD: 2.26%
• 6M: -1.07%
• 1Y: 27.58%
• 3Y*: 32.88%
• 5Y*: 10.86%
• 10Y*: 33.14%

AU

• 1D: 3.75%
• 1M: -14.67%
• YTD: 4.15%
• 6M: 7.11%
• 1Y: 86.54%
• 3Y*: 58.20%
• 5Y*: 35.46%
• 10Y*: 20.46%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ASND vs. AU - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ASND Ascendis Pharma A/S	2.26%	54.89%	9.31%	3.13%	-9.22%	-19.34%	19.88%	122.06%	56.39%	97.92%
AU AngloGold Ashanti Limited	4.15%	288.18%	25.43%	-2.68%	-5.09%	-4.87%	1.90%	78.89%	23.96%	-2.23%

Correlation

The correlation between ASND and AU is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.13
Correlation (3Y) Calculated over the trailing 3-year period	0.13
Correlation (5Y) Calculated over the trailing 5-year period	0.10
Correlation (10Y) Calculated over the trailing 10-year period	0.05
Correlation (All Time) Calculated using the full available price history since Jan 28, 2015	0.04

Fundamentals

Market Cap ASND : $14.07B AU : $43.57B
EPS ASND : €8.08 AU : $6.85
PE Ratio ASND : 23.32 AU : 12.59
PEG Ratio ASND : 0.11 AU : 0.15
PS Ratio ASND : 13.62 AU : 3.92
PB Ratio ASND : 24.89 AU : 5.11
Total Revenue (TTM) ASND : €867.51M AU : $11.17B
Gross Profit (TTM) ASND : €764.89M AU : $5.82B
EBITDA (TTM) ASND : -€6.94M AU : $5.58B

Return for Risk

ASND vs. AU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASND

ASND Risk / Return Rank: 68
ASND Sharpe Ratio Rank: 67
ASND Sortino Ratio Rank: 63
ASND Omega Ratio Rank: 60
ASND Calmar Ratio Rank: 72
ASND Martin Ratio Rank: 76

AU

AU Risk / Return Rank: 79
AU Sharpe Ratio Rank: 83
AU Sortino Ratio Rank: 77
AU Omega Ratio Rank: 77
AU Calmar Ratio Rank: 80
AU Martin Ratio Rank: 81

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASND vs. AU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ascendis Pharma A/S (ASND) and AngloGold Ashanti Limited (AU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ASND	AU	Difference
Sharpe ratio: Return per unit of total volatility	0.75	1.50	-0.74
Sortino ratio: Return per unit of downside risk	1.28	1.95	-0.67
Omega ratio: Gain probability vs. loss probability	1.15	1.26	-0.10
Calmar ratio: Return relative to maximum drawdown	1.59	2.35	-0.76
Martin ratio: Return relative to average drawdown	4.87	6.18	-1.31

ASND vs. AU - Sharpe Ratio Comparison

The current ASND Sharpe Ratio is 0.75, which is lower than the AU Sharpe Ratio of 1.50. The chart below compares the historical Sharpe Ratios of ASND and AU, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ASND vs. AU - Drawdown Comparison

The maximum ASND drawdown since its inception was -61.72%, smaller than the maximum AU drawdown of -90.12%. Use the drawdown chart below to compare losses from any high point for ASND and AU.

Drawdown Indicators

	ASND	AU	Difference
Max Drawdown Largest peak-to-trough decline	-61.72%	-90.12%	+28.40%
Max Drawdown (1Y) Largest decline over 1 year	-17.62%	-37.03%	+19.41%
Max Drawdown (3Y) Largest decline over 3 years	-29.15%	-38.71%	+9.56%
Max Drawdown (5Y) Largest decline over 5 years	-60.46%	-51.75%	-8.71%
Max Drawdown (10Y) Largest decline over 10 years	-61.72%	-67.91%	+6.19%
Current Drawdown Current decline from peak	-12.72%	-30.75%	+18.03%
Average Drawdown Average peak-to-trough decline	-18.90%	-46.07%	+27.17%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.72%	14.04%	-8.32%

Volatility

ASND vs. AU - Volatility Comparison

The current volatility for Ascendis Pharma A/S (ASND) is 13.12%, while AngloGold Ashanti Limited (AU) has a volatility of 21.02%. This indicates that ASND experiences smaller price fluctuations and is considered to be less risky than AU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ASND	AU	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.12%	21.02%	-7.90%
Volatility (6M) Calculated over the trailing 6-month period	29.45%	46.50%	-17.05%
Volatility (1Y) Calculated over the trailing 1-year period	37.26%	58.45%	-21.19%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	48.65%	49.13%	-0.48%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	51.09%	49.79%	+1.30%

Dividends

ASND vs. AU - Dividend Comparison

ASND has not paid dividends to shareholders, while AU's dividend yield for the trailing twelve months is around 5.33%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
ASND Ascendis Pharma A/S	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
AU AngloGold Ashanti Limited	5.33%	2.96%	1.78%	1.14%	2.26%	2.58%	0.49%	0.30%	0.48%	0.93%

Financials

Frequently Asked Questions

Can I hold both ASND and AU in my portfolio?

ASND and AU have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ASND or AU?

AU has higher volatility (21.02%) compared to ASND (13.12%). In terms of maximum drawdown, ASND dropped -61.72% vs AU's -90.12%.

Which has better risk-adjusted returns?

AU currently has the higher Sharpe Ratio (1.50 vs 0.75), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.